# Alpha Tau Medical: Alpha Radiation Cancer Treatment

> Alpha TAU Medical is a clinical\-stage oncology company pioneering intratumoral alpha\-emitting radiotherapeutics to address multiple solid tumor types, including those with few or no currently viable treatment options

Generated by Yoast SEO v28.7, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [News Room](https://alphatau.com/newsroom/)
- [Cancer du pancréas](https://alphatau.com/fr/indications-therapeutiques/pancreatic-cancer-fr/)
- [Cancer de la prostate](https://alphatau.com/fr/indications-therapeutiques/prostate-cancer-fr/)
- [Indications thérapeutiques](https://alphatau.com/fr/indications-therapeutiques/)
- [Cancer de la peau, de la tête et du cou](https://alphatau.com/fr/indications-therapeutiques/skin-head-neck-cancer-fr/)

## Posts
- [Alpha Tau to Participate in October Investor Conferences](https://alphatau.com/alpha-tau-to-participate-in-october-investor-conferences/)
- [לקראת סיומה של שנת תשפ״ו וכניסתה של שנת תשפ״ז](https://alphatau.com/לקראת-סיומה-של-שנת-תשפ״ו-וכניסתה-של-שנת/)
- [Reflections as we prepare for the Jewish New Year](https://alphatau.com/reflections-as-we-prepare-for-the-jewish-new-year/)
- [Alpha Tau to Participate in September Investor Conferences](https://alphatau.com/alpha-tau-to-participate-in-september-investor-conferences/)
- [Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions](https://alphatau.com/alpha-tau-completes-patient-enrollment-in-its-multicenter-impact-pancreatic-cancer-pilot-study-of-alpha-dart-following-strong-demand-and-multiple-expansions/)

## JetPopup
- [Person](https://alphatau.com/jet-popup/person/)

## Career
- [Clinical Product Specialist](https://alphatau.com/career/clinical-product-specialist/)
- [Product Engineering Manager](https://alphatau.com/career/physicist-2/)

## From The Media
- [Alpha Tau CFO Raphi Levy breaks down Alpha DaRT on The Big Biz Show](https://alphatau.com/from_the_media/alpha-tau-cfo-raphi-levy-breaks-down-alpha-dart-on-the-big-biz-show/)
- [The Next Big Thing \- Interview with Uzi Sofer, Alpha Tau CEO on Alpha Tau, Alpha DaRT and leadership](https://alphatau.com/from_the_media/the-next-big-thing-interview-with-uzi-sofer-alpha-tau-ceo-on-alpha-tau-alpha-dart-and-leadership/)
- [Tel Aviv \- New York \- Interview with Alpha Tau CEO following regulatory approval for Alpha DaRT in Japan](https://alphatau.com/from_the_media/tel-aviv-new-york-interview-with-alpha-tau-ceo-following-regulatory-approval-for-alpha-dart-in-japan/)
- [Smart Money Circle Show Hosted By Adam Sarhan  \- Interview with Alpha Tau CFO, Raphi Levy](https://alphatau.com/from_the_media/smart-money-circle-show-hosted-by-adam-sarhan-interview-with-alpha-tau-cfo-raphi-levy/)
- [How recurrent disease is driving the search for new treatment options](https://alphatau.com/from_the_media/how-recurrent-disease-is-driving-the-search-for-new-treatment-options/)

## Publications
- [Endoscopic ultrasound–guided intratumoral alpha radiotherapy: clinical implementation of a novel therapeutic delivery platform](https://alphatau.com/publications/endoscopic-ultrasound-guided-intratumoral-alpha-radiotherapy-clinical-implementation-of-a-novel-therapeutic-delivery-platform/)
- [Effect of intratumoral alpha radiation on tumor growth delay and tumor microenvironment in an orthotopic colorectal liver metastasis murine model](https://alphatau.com/publications/diffusion-of-the-alpha-particle-emitting-daughters-of-alpha-dart-sources-in-an-orthotopic-murine-model-of-colorectal-adenocarcinoma/)
- [Diffusion of the alpha\-particle emitting daughters of alpha\-DaRT sources in an orthotopic murine model of colorectal adenocarcinoma](https://alphatau.com/publications/diffusion-of-the-alpha-particle-emitting-daughters-of-alpha-dart-sources-in-an-orthotopic-murine-model-of-colorectal-adenocarcinoma-2/)
- [Exploring the therapeutic potential of localized alpha irradiation for cancer: from DNA damage to immune activation](https://alphatau.com/publications/exploring-the-therapeutic-potential-of-localized-alpha-irradiation-for-cancer-from-dna-damage-to-immune-activation-2/)
- [A finite element method for modeling diffusion of alpha\-emitting particles in tissue](https://alphatau.com/publications/a-finite-element-method-for-modeling-diffusion-of-alpha-emitting-particles-in-tissue/)

## Events
- [Barclays 29th Annual Global Healthcare Conference](https://alphatau.com/events/barclays-29th-annual-global-healthcare-conference/)
- [ASTRO 2026](https://alphatau.com/events/astro-2026/)
- [31st Annual Meeting \& Education Day of the Society for Neuro\-Oncology \(SNO 2026\)](https://alphatau.com/events/31st-annual-meeting-education-day-of-the-society-for-neuro-oncology-sno-2026/)
- [Citi’s 2027 Virtual Oncology Leadership Summit](https://alphatau.com/events/citis-2026-global-healthcare-conference-2/)
- [Citi's 2026 Global Healthcare Conference](https://alphatau.com/events/citis-2026-global-healthcare-conference/)

## Clinical Trials
- [REGAIN \- Recurrent Glioblastoma Alpha\-DaRT Intratumoral Therapy trial\.](https://alphatau.com/clinical-trials/a-study-to-assess-the-feasibility-and-safety-of-intratumoral-diffusing-alpha-emitters-for-the-treatment-of-recurrent-glioblastoma/)
- [ReSTART \- Recurrent SCC \(Squamous Cell Carcinoma\) Treatment with Alpha DaRT Radiotherapeutics](https://alphatau.com/clinical-trials/a-clinical-study-to-assess-the-efficacy-and-safety-of-alpha-dart224-for-the-treatment-of-patients-with-recurrent-cutaneous-squamous-cell-carcinoma/)
- [ADMIRE \- Alpha Dart Management for Immunocompromised patients with REcurrent cSCC](https://alphatau.com/clinical-trials/clinical-study-protocol-for-cutaneous-scc-for-immunocompromised-patients-dart/)
- [ACAPELLA \- Alpha DArT for CAncer of the PancrEas in Locally Advanced Adenocarcinoma](https://alphatau.com/clinical-trials/alpha-radiation-emitters-device-dart-for-the-treatment-of-locally-advanced-pancreatic-cancer/)
- [Alpha Radiation Emitters Device \(DaRT\) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia](https://alphatau.com/clinical-trials/alpha-radiation-emitters-device-dart-for-the-treatment-of-cutaneous-mucosal-or-superficial-soft-tissue-neoplasia-2/)

## Leadership \& Board
- [Peter Melnyk](https://alphatau.com/fr/leadership-and-board/peter-melnyk-2/)
- [Dr\. Stephen Hahn](https://alphatau.com/fr/leadership-and-board/dr-stephen-hahn-2/)
- [Pr Yona Keisari](https://alphatau.com/fr/leadership-and-board/pr-yona-keisari/)
- [Pr Aron Popovtzer](https://alphatau.com/fr/leadership-and-board/pr-aron-popovtzer/)
- [Pr Michael J\. Zelefsky, M\.D\.](https://alphatau.com/fr/leadership-and-board/pr-michael-j-zelefsky-m-d/)

## Categories
- [Press Releases](https://alphatau.com/category/press-releases/)
- [Blog](https://alphatau.com/category/blog/)

## Therapeutic Areas
- [Skin](https://alphatau.com/therapeutic-areas/skin/)
- [Pancreas](https://alphatau.com/therapeutic-areas/pancreas/)
- [Prostate](https://alphatau.com/therapeutic-areas/prostate/)
- [Brain](https://alphatau.com/therapeutic-areas/brain/)
- [Lungs](https://alphatau.com/therapeutic-areas/lung/)

## Optional
- [Sitemap index](https://alphatau.com/sitemap_index.xml)